MedTrace Logo

Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis

NCT04130100 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-10-17

No results posted yet for this study

Summary

To evaluate the clinical efficacy and safety of dental pulp mesenchymal stem cells in the treatment of primary mild to moderate knee osteoarthritis through a comparative study with sodium hyaluronate.

20 participants will receive low dose of dental pulp mesenchymal stem cells, 20 participants will receive high dose and another 20 participants will receive sodium hyaluronate

Conditions

Interventions

BIOLOGICAL

Low Dose of Mesenchymal stem cell

Mesenchymal stem cell injection

BIOLOGICAL

High Dose of Mesenchymal stem cell

Mesenchymal stem cell injection

DRUG

Sodium Hyaluronate

Sodium Hyaluronate injection

Sponsors & Collaborators

  • CAR-T (Shanghai) Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Dongbao Zhao, Doctor · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-04
Primary Completion
2021-09-30
Completion
2021-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04130100 on ClinicalTrials.gov